The Emerging Role of Multimodal Artificial Intelligence in Urological Surgery
Current Oncology · 2025
DOI: 10.3390/curroncol32120665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2025. Verfasst von Leonhard Buck und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany. Hauptthemen laut MEDLINE: Artificial Intelligence, Urologic Surgical Procedures, Urologic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multimodal artificial intelligence (MMAI) is transforming urological oncology by enabling the seamless integration of diverse data sources, including imaging, clinical records and robotic telemetry to facilitate patient-specific decision-making.
Methods
This narrative review summarizes the current developments, applications, opportunities and risks of multimodal AI systems throughout the entire perioperative process in uro-oncologic surgery.
Results
MMAI demonstrates quantifiable benefits across the entire perioperative pathway. Preoperatively, it improves diagnostics and surgical planning via multimodal data fusion. Intraoperatively, AI-assisted systems provide real-time context-based decision support, risk prediction and skill assessment within the operating theater. Postoperatively, MMAI facilitates automated documentation, early complication detection and personalized follow-up. Generative AI further revolutionizes surgical training through adaptive feedback and simulations. However, critical limitations must be addressed, including data bias, the barrier of closed robotic platforms, insufficient model validation, data security issues, hallucinations and ethical concerns regarding liability and transparency.
Conclusions
MMAI significantly enhances the precision, efficiency and patient-centeredness of uro-oncological care. To ensure safe and widespread implementation, resolving the technical and regulatory barriers to real-time integration into robotic platforms is paramount. This must be coupled with standardized quality controls, transparent decision-making processes and responsible integration that fully preserves physician autonomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
- Kurt-Semm Center for Laparoscopic and Robotic Surgery, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
- Department of Pathology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
- Working Group on Artificial Intelligence and Digitalization of the German Society of Urology.
ORCID-Profile: Leonhard Buck, Jakob Kohler, Julian Risch
Zitieren
APA
Buck, L., Kohler, J., Risch, J., Incesu, R. B., Hügelmann, K., Weiss, M. L., Weische, O., Schließer, P., von Knobloch, H. C., Blessin, N. C., Bach, T., Jarczyk, J., Nuhn, P., & Rodler, S. (2025). The Emerging Role of Multimodal Artificial Intelligence in Urological Surgery. Current Oncology. https://doi.org/10.3390/curroncol32120665
Vancouver
Buck L, Kohler J, Risch J, Incesu RB, Hügelmann K, Weiss ML, et al. The Emerging Role of Multimodal Artificial Intelligence in Urological Surgery. Current Oncology. 2025. doi:10.3390/curroncol32120665
BibTeX
@article{Buck2025,
author = {Buck, Leonhard and Kohler, Jakob and Risch, Julian and Incesu, Reha-Baris and Hügelmann, Konrad and Weiss, Marie-Luise and Weische, Oscar and Schließer, Patricia and von Knobloch, Hans Christoph and Blessin, Niclas C and Bach, Thorsten and Jarczyk, Jonas and Nuhn, Philipp and Rodler, Severin},
title = {The Emerging Role of Multimodal Artificial Intelligence in Urological Surgery},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32120665}
}
EUVIMED